Loading...
•
Dec 31, 2024
Assertio Q4 2024 Earnings Report
Assertio reported a decline in revenue and net income for Q4 2024, with lower gross margin and higher litigation-related expenses.
Key Takeaways
Assertio's Q4 2024 net product sales totaled $29.6 million, reflecting a decline from the prior year. Gross margin fell to 61% due to higher inventory write-downs. The company reported a GAAP net loss of $10.5 million, while adjusted EPS was -$0.03. Free cash flow remained positive at $11.5 million.
Net product sales were $29.6 million, down from $32.5 million in Q4 2023.
Gross margin declined to 61% due to inventory write-downs.
Adjusted EBITDA was a loss of $0.5 million, compared to a gain of $4.5 million in Q4 2023.
Free cash flow remained positive at $11.5 million.
Assertio
Assertio
Assertio Revenue by Segment
Revenue by Segment
Net Product Sales Revenue
CapyFin.com Forward Guidance
Assertio expects net product sales between $108 million and $123 million for FY 2025, with a focus on revenue growth from Rolvedon and Sympazan.
Positive Outlook
- Projected revenue growth from Rolvedon and Sympazan.
- Operational cost efficiencies expected to improve margins.
- Continued free cash flow generation.
- Potential acquisitions to expand the company's portfolio.
- Stronger balance sheet with increased cash reserves.
Challenges Ahead
- Net sales decline expected in legacy products.
- Litigation expenses may continue to impact profitability.
- Potential headwinds from generic competition.
- Macroeconomic uncertainty affecting demand.
- Ongoing restructuring costs may weigh on short-term earnings.